May 27, 2006|
Up for grabs!
As is known, the last week saw significant volatility. While market participants attributed the same to unwinding of open interest positions in the futures market and margin trading-related issues, what investors are also overseeing is that many of the global markets also witnessed selling pressure. Yes, FIIs were net sellers, but domestic mutual funds were huge buyers. All in all, the last week was an acid test as far as investor confidence was concerned.
As far as the institutional activity on the bourses is concerned, as we had mentioned earlier, Foreign Institutional Investors (FIIs) were net sellers to the tune of Rs 71.0 bn over the last five days. But at the same time, domestic mutual funds, which were sitting on cash prior to the fall in the stock market, have been opportunistic. As of April 2006, the total assets under management with the domestic mutual funds (MFs) (only growth, balanced and tax savings schemes) were Rs 247.5 bn. Assuming even 15% of this as cash holdings, the investable corpus works out to Rs 37.1 bn (the percentage of cash in a portfolio varies fund to fund). Net investment by the domestic mutual funds in the last one week actually stood at Rs 33.5 bn! Besides, based on our interaction with select mutual funds, there have not been any significant redemption pressures in the last week, which is heartening.
Net investments - Contratrians in actionů
The last week also witnessed corporates announcing their full year results. Unlike the last eight quarters, corporate performance has been mixed in the last quarter. While the likes of HPCL surprised the markets (operating profit grew by more than 3.2 times in 4QFY06), the performance of SAIL and OBC were lackluster. The combined topline growth for the Quantum Universe companies (around 300) in 4QFY06 was 24% YoY, while the net profit grew by 35% YoY. In our view, we expect earnings growth to slowdown in light of higher input costs, increased capital expenditure and higher base effect.
Top gainers during the week (NSE-50)
May 26 (Rs)
May 19 (Rs)
|| 12,671 / 6,439
|S&P CNX NIFTY
|| 3,774 / 1,976
||679 / 329
||1,061 / 370
||305 / 113
||128 / 49
||706 / 459
Having looked the institutional activity and select corporate result announcements in the last one-week, let us consider some sector/stock specific developments:
Domestic pharma heavyweight, Ranbaxy, entered into an in-licensing agreement with Ethypharm LL India, wholly-owned subsidiary of Ethypharm, the leading French drug delivery company. The agreement is for the domestic market and would involve marketing of Ethypharm's painkiller drug, Tramadol 50 mg. The product will be supplied from the French major's manufacturing facility near Mumbai, and will be marketed and distributed by Ranbaxy under its brand name 'Trambax'. The marketing rights for the drug in the domestic territory will thus provide Ranbaxy a way to grow is India revenues faster. India currently contributes to around 22% of the company's total revenues. Ranbaxy was down 1.4% over the last one week. Other Pharma Stocks
NTPC, the country's largest power producer, is planning to set up a series of merchant power plants for direct sale of electricity to bulk consumers. Currently, its entire power generation is sold to states at a break-even cost under long-term power purchase agreements with state electricity boards (SEBs). The proposed plants will give the company an opportunity to sell electricity on better commercial terms to bulk buyers, either under long-term bilateral deals or under forward trading or in the spot market. It has identified four hydel power projects (totaling 1,551 mw) to be set up as merchant power plants in Uttaranchal. Compared with a traditional rate-based power plant, a merchant power plant sells electricity in the wholesale power market without requiring to serve any specific consumer. Moreover, returns from a merchant power project are much higher. At present, NTPC sells power at an average cost of Rs 1.6 a unit, while the cost of Selectricity to be sold from the proposed merchant power plants would fetch around Rs 6 a unit. This will help the company to increase its topline going forward. The stock was marginally down over the last one week. Top losers during the week (NSE-50)
May 26 (Rs)
May 19 (Rs)
||1,514 / 854
||613 / 364
||1,754 / 693
||1,420 / 747
||2,915 / 1,034
TVS Motors is in talks with a Brazilian automobile manufacturer to set up an assembly joint venture for two wheelers. The plant will be set up in Brazil and will cater to the Mercosur region, which is a 1 m two- wheeler market. The company plans to introduce the complete range of two wheelers starting from step-thrus to regular models. It had recently announced its plans to set up another assembly plant in Columbia. These regions cover the entire South American market sized at 1.4 m and growing at the rate of 10% pa. This will help TVS Motors to venture into new geographies and diversify its revenue stream. The stock was down around 2% in the last week. Other Automobile Stocks.
Dabur is planning to focus on the fruit drinks market after having captured 58% of the fruit juice market with its brand 'Real'. The fruit drinks market is pegged at Rs 12.5 bn and the company is aiming to re-launch its brand 'Coolers' to capture a significant portion of this market. Currently, Dabur enjoys less than 1% market share in this segment. This move is a positive for Dabur as the fruit drinks market is growing at a rate of over 50% per annum. Dabur is aiming to corner around 5% to 8% of this market in the next three years. Other FMCG Stocks
As is known and discussed threadbare, it is difficult to take a call on what FIIs will be doing going forward. We again re-iterate that one should not base his/her investment decision on FIIs. Many stocks have fallen significantly over the last one-month and we believe that it is time to start allocating money towards equities. As far as sectors are concerned, we have a cautious view on commodities (steel in particular) and current valuations of FMCG and engineering companies. The fact remains that equities are a risky asset class and tend to be volatile. But if is careful in stock selection, the day-to-day movement should not be a big cause of concern. Happy investing!
More Views on News
Jun 10, 2017
Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.
Aug 18, 2017
Buying the index now will hardly help make money in stocks even in ten years.
Aug 18, 2017
Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.
Aug 17, 2017
PersonalFN simplifies the mutual fund account statement for you.
Aug 17, 2017
A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407